Busey Bank’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $702K | Sell |
1,338
-113
| -8% | -$59.3K | 0.02% | 209 |
|
|
2025
Q1 | $920K | Sell |
1,451
-39
| -3% | -$24.7K | 0.03% | 174 |
|
|
2024
Q4 | $1.06M | Sell |
1,490
-73
| -5% | -$52K | 0.03% | 167 |
|
|
2024
Q3 | $1.64M | Sell |
1,563
-227
| -13% | -$239K | 0.05% | 147 |
|
|
2024
Q2 | $1.88M | Sell |
1,790
-92
| -5% | -$96.7K | 0.06% | 139 |
|
|
2024
Q1 | $1.81M | Sell |
1,882
-115
| -6% | -$111K | 0.06% | 142 |
|
|
2023
Q4 | $1.75M | Buy |
1,997
+16
| +0.8% | +$14.1K | 0.07% | 141 |
|
|
2023
Q3 | $1.63M | Sell |
1,981
-319
| -14% | -$263K | 0.07% | 136 |
|
|
2023
Q2 | $1.65M | Sell |
2,300
-52
| -2% | -$37.4K | 0.07% | 140 |
|
|
2023
Q1 | $1.93M | Sell |
2,352
-67
| -3% | -$55.1K | 0.08% | 134 |
|
|
2022
Q4 | $1.75M | Sell |
2,419
-33
| -1% | -$23.8K | 0.08% | 140 |
|
|
2022
Q3 | $1.69M | Sell |
2,452
-137
| -5% | -$94.4K | 0.08% | 139 |
|
|
2022
Q2 | $1.53M | Sell |
2,589
-387
| -13% | -$229K | 0.07% | 151 |
|
|
2022
Q1 | $2.08M | Sell |
2,976
-35
| -1% | -$24.4K | 0.08% | 148 |
|
|
2021
Q4 | $1.9M | Sell |
3,011
-129
| -4% | -$81.4K | 0.07% | 157 |
|
|
2021
Q3 | $1.9M | Sell |
3,140
-332
| -10% | -$201K | 0.08% | 149 |
|
|
2021
Q2 | $1.94M | Sell |
3,472
-139
| -4% | -$77.7K | 0.09% | 135 |
|
|
2021
Q1 | $1.71M | Sell |
3,611
-245
| -6% | -$116K | 0.09% | 139 |
|
|
2020
Q4 | $1.86M | Sell |
3,856
-160
| -4% | -$77.3K | 0.11% | 132 |
|
|
2020
Q3 | $2.25M | Sell |
4,016
-64
| -2% | -$35.8K | 0.14% | 118 |
|
|
2020
Q2 | $2.55M | Sell |
4,080
-69
| -2% | -$43K | 0.18% | 109 |
|
|
2020
Q1 | $2.03M | Sell |
4,149
-19
| -0.5% | -$9.27K | 0.16% | 115 |
|
|
2019
Q4 | $1.57M | Sell |
4,168
-735
| -15% | -$276K | 0.1% | 146 |
|
|
2019
Q3 | $1.36M | Buy |
+4,903
| New | +$1.36M | 0.1% | 149 |
|